← SynDRA
MK-0557
SynDRA canonical compound SYN0020397 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | NPY5R |
|---|
| Mechanism of action | neuropeptide receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- NPY5R ANTAGONIST
- Neuropeptide Y receptor type 5 antagonist
- neuropeptide receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADGRF1
- HRH3
- HTR1B
- HTR1E
- HTR2A
- HTR2B
- HTR2C
- HTR6
- NEIL1
- NEIL2
- NTHL1
- OGG1
- OPRD1
- OPRK1
- OPRM1
- S1PR1
- SIGMAR1
- SMUG1
- TDG
- TMEM97
- TSPO
- HTR1A
- HRH2
- ADRA1B
- HRH1
- ADRA2A
- ADRB2
- ADRB3
- AGTR1
- APLNR
- C5AR1
- CHRM1
- CHRM2
- CHRM3
- CHRM5
- CX3CR1
- DRD2
- DRD3
- DRD5
- FFAR4
Cross-references
Synonyms
Look up MK-0557 in the interactive SynDRA portal →